Coumarin343

CAS No. 55804-65-4

Coumarin343( —— )

Catalog No. M36948 CAS No. 55804-65-4

Coumarin343 inhibits monocarboxylic acid transporter protein 4 with IC50 values in the range of 0.01-100 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 In Stock
100MG 59 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Coumarin343
  • Note
    Research use only, not for human use.
  • Brief Description
    Coumarin343 inhibits monocarboxylic acid transporter protein 4 with IC50 values in the range of 0.01-100 μM.
  • Description
    Coumarin 343 (C343) is a hydrophilic fluorescent probe for the micro water pool. λem is approximately 425 nm andλem is approximately from 425 nm to 550 nm by RF-1500.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Monocarboxylate Transporter
  • Recptor
    Monocarboxylate transporter | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55804-65-4
  • Formula Weight
    285.29
  • Molecular Formula
    C16H15NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)c1cc2cc3CCCN4CCCc(c34)c2oc1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Keiju Yamazaki, et al. Fluorometric analysis on physicochemical properties of phosphatidylcholine-based W/O microemulsion involved with enzymatic reactivity in phospholipid hydrolysis. Korean Journal of Chemical Engineering volume 25, pages 1439–1443 (2008).
molnova catalog
related products
  • BAY8002

    BAY-8002 is a potent dual MCT1/2 inhibitor (IC50 values are 3 8 and 12 nM at rat (C6) human (DLD-1) and mouse (4T1) MCT1 respectively).

  • MSC-4381

    MSC-4381 (MCT4-IN-1) is an orally available and selectively modeled highly potent inhibitor of monocarboxylic acid transporter protein 4 (MCT4/SLC16A3) with potential anticancer and antitumor activity for the study of osteosarcoma.

  • MCT1-IN-3

    MCT1-IN-3 is a monocarboxylate transporter 1 (MCT1) inhibitor, targeting solute carrier (SLC) monocarboxylate transporter 1 (MCT1; SLC16A1) for cancer treatment.